SCHEMBL30123081

SCHEMBL30123081

CC(C)C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.65
▸ OPRD1 P41143 4/20 0.65
▸ NPY4R P50391 7/20 0.55
▸ NPY1R P25929 5/20 0.55
▸ NPY2R P49146 3/20 0.55
▸ FOLH1 Q04609 1/20 0.53
▸ OPRK1 P41145 1/20 0.51
▸ NPY5R Q15761 2/20 0.50
▸ IL1RN P18510 1/20 0.50
▸ ERAP2 Q6P179 1/20 0.50
▸ ACE P12821 1/20 0.50
▸ SLC6A2 P23975 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30538854 0.92 OPRM1 (0.56) OPRM1OPRD1NPY4RNPY1RNPY2R
SCHEMBL29772603 0.91 OPRD1 (0.58) OPRM1OPRD1NPY4RNPY1RNPY2R
SCHEMBL30504227 0.91 OPRM1 (0.62) OPRM1OPRD1
SCHEMBL29528212 0.90 OPRD1 (0.57) OPRM1OPRD1NPY4RNPY1RNPY2R
SCHEMBL30839485 0.90 OPRD1 (0.64) OPRM1OPRD1NPY4RNPY1RNPY2R
SCHEMBL30839484 0.90 OPRD1 (0.64) OPRM1OPRD1NPY4RNPY1RNPY2R
SCHEMBL29822758 0.89 FOLH1 (0.66) NPY4RNPY1RNPY2RFOLH1NPY5R
SCHEMBL31720934 0.89 ACE (0.56) OPRM1OPRD1NPY4RNPY1RNPY2R
SCHEMBL29823718 0.89 OPRD1 (0.70) OPRM1OPRD1OPRK1SLC6A2
SCHEMBL29734944 0.88 FOLH1 (0.68) OPRM1OPRD1NPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370150-A1 OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS Intervet International B.V. (NL) 2024-05-22 — — EP disclosed
WO-2023285489-A1 OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS INTERVET INTERNATIONAL B.V. (NL) 2023-01-19 — — WO disclosed
Send feedback